OncoTherapy Science
4564.TTSE GROWTHPharmaceutical
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Yusuke Nakamura | 6.05% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 1
| Long Corridor Asset Management Limited | 4.63% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Long Corridor Asset Management Limited2024-07-01 | 8.46% | -1.41pp |
| Long Corridor Asset Management Limited2024-06-18 | 9.87% | no change |
| Long Corridor Asset Management Limited2024-06-10 | 9.87% | -2.02pp |
| Long Corridor Asset Management Limited2024-06-07 | 11.89% | -0.74pp |
| Long Corridor Asset Management Limited2024-05-28 | 12.63% | -3.57pp |
| Long Corridor Asset Management Limited2024-05-24 | 16.20% | no change |
| Long Corridor Asset Management Limited2024-05-23 | 16.20% | -1.47pp |
| Long Corridor Asset Management Limited2024-05-16 | 17.67% | -0.74pp |
| Long Corridor Asset Management Limited2024-05-08 | 18.41% | -1.47pp |
| Long Corridor Asset Management Limited2024-05-07 | 19.88% | -0.74pp |
| Long Corridor Asset Management Limited2024-04-25 | 20.62% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.